Favipiravir Effectiveness and Safety in Hospitalized Moderate-Severe COVID-19 Patients: Observational Prospective Multicenter Investigation in Saudi Arabia

OBJECTIVES: There are limited data on the efficacy and safety of favipiravir antiviral in coronavirus disease 2019 (COVID-19), particularly in the more progressed disease phase. This study aims to evaluate the favipiravir effect on reducing the length of hospital stay and in-hospital mortality among...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Muhsen, Saleh, Al-Numair, Nouf S., Saheb Sharif-Askari, Narjes, Basamh, Roaa, Alyounes, Banan, Jabaan, Amjad, Saheb Sharif-Askari, Fatemeh, Alosaimi, Mohammed F., Alsohime, Fahad, Halwani, Rabih, Al-Saud, Haya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931493/
https://www.ncbi.nlm.nih.gov/pubmed/35308532
http://dx.doi.org/10.3389/fmed.2022.826247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931493/
https://www.ncbi.nlm.nih.gov/pubmed/35308532
http://dx.doi.org/10.3389/fmed.2022.826247

Ejemplares similares